Appistry's GenomePilot Now Available on Microsoft Azure

ST. LOUIS--(BUSINESS WIRE)--Appistry, Inc., a leading provider of software and services that enable healthcare institutions to practice genomically enhanced medicine, announced today the availability of GenomePilot on Microsoft's Azure Marketplace. Through a new collaboration, Appistry will actively participate with Microsoft and other partners in the development of a complete set of cloud-based services for research and clinical genomics.

Appistry will be working closely with Microsoft to develop, market, and sell genomics services on Azure, Microsoft's cloud computing platform and integrated services that enable organizations to build and manage enterprise, production-grade infrastructures and applications easily, quickly, and cost-effectively. For an initial offering, Appistry is delivering its GenomePilot data analysis application on Azure to help research and clinical laboratories process and analyze the high volumes of genomics data produced by next-generation sequencing (NGS) technology.

"Clinical labs value GenomePilot because it's easy to use and deploy, enabling them to deliver high-quality, actionable results from sequencing data in days rather than weeks or months, while maintaining a detailed record of every action to meet compliance requirements, enabling the lab's clinical use of the data," said Kevin Haar, chief executive officer of Appistry. "We're excited to deliver this application in concert with Azure's proven infrastructure and capabilities so that more research and clinical labs can capitalize on genomics data to advance precision, personalized medicine."

Initially released by Appistry in April 2015, GenomePilot provides a turnkey solution for NGS analysis by integrating tools, data, and processes into a single solution to help labs streamline their NGS analyses and increase productivity. For clinical labs operating under HIPAA or CLIA regulation, GenomePilot tracks all information associated with analysis runs for compliance auditing. Deployed on Azure, GenomePilot enables organizations to take advantage of these capabilities on a flexible, security-enhanced cloud infrastructure.

"We are excited that Appistry's GenomePilot is now available in the Azure Marketplace," said Nicole Herskowitz, Senior Director of Product Marketing, Microsoft Azure. "GenomePilot on Azure will help healthcare organizations make optimal use of data to diagnose disease, develop precision treatments, and understand the causes of genetic disorders ranging from inherited cancers to rare and complex childhood conditions."

The initial offering of GenomePilot on Azure can be found by visiting http://azure.microsoft.com/en-us/marketplace/partners/appistry/genomepilot/.

More information about the latest version of GenomePilot can be found by visiting www.appistry.com/genomepilot.

About Appistry

Appistry, Inc., helps clinical labs, research institutions, and hospitals capitalize on genomics data so that they can practice genomically enhanced medicine. Our world-class bioinformatics tools, cloud services, and software streamline the analysis of NGS data and make genome-scale data actionable in guiding research projects and informing clinical decisions. Learn more by connecting with Appistry on Facebook, Twitter and LinkedIn.

Contacts